CLINICAL TRIALS PROFILE FOR NEXCEDE
✉ Email this page to a colleague
All Clinical Trials for NEXCEDE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02099006 ↗ | Novel Topical Therapies for the Treatment of Genital Pain | Completed | Mae Stone Goode Foundation | Phase 2/Phase 3 | 2013-11-01 | This study is testing drugs not previously used topically for the treatment of vulvodynia, a common genital pain syndrome. It is hoped that one of these drugs will improve vaginal entryway pain with touch, daily pain scores and sexual functioning. |
NCT02099006 ↗ | Novel Topical Therapies for the Treatment of Genital Pain | Completed | University of Rochester | Phase 2/Phase 3 | 2013-11-01 | This study is testing drugs not previously used topically for the treatment of vulvodynia, a common genital pain syndrome. It is hoped that one of these drugs will improve vaginal entryway pain with touch, daily pain scores and sexual functioning. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for NEXCEDE
Condition Name
Clinical Trial Locations for NEXCEDE
Trials by Country
Clinical Trial Progress for NEXCEDE
Clinical Trial Phase
Clinical Trial Sponsors for NEXCEDE
Sponsor Name